Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
Zacks.com on MSN7h
LLY Oral Cholesterol Drug Lowers Lipoprotein Levels in Phase II Study
Eli Lilly LLY announced that its investigational oral, once-daily cholesterol-lowering drug muvalaplin reduced lipoprotein(a) ...
News Medical8h
New research links sphingolipids to heart disease and atherosclerosis
Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns.
STAT18h
Two drugs look promising for lipoprotein(a), a common genetic risk factor for heart disease
At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...
New guidelines aim to reduce stroke risk with lifestyle changes and medication
New guidelines from the American Stroke Association aim to reduce the risk of stroke, a condition that affects more than half ...
Health.com6d
13 Common Medications You Should Never Mix with Alcohol
Alcohol can change how your body breaks down and absorbs medications, causing adverse reactions, and even overdose. Here are ...